Anti-RON antibodies

Monoclonal antibodies that bind and inhibit activation of human RON (Recepteur d' Origine Nantais) are disclosed. The antibodies can be used to treat certain forms of cancer that are associated with activation of RON.

Saved in:
Bibliographic Details
Main Authors BREAULT LYNE, LIU QING, GIFFORD JAMES, CHEN TING, BOTTEGA STEVE, WEILER SOLLY, MEETZE KRISTAN, WHALEN KERRY, JIANG JINWEI, BOUDROW ANDREA, VINCENT SYLVIE, GYURIS JENO, WINSTON, JR. WILLIAM M, HAN MAY, LERNER LORENA
Format Patent
LanguageEnglish
Published 10.12.2013
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Monoclonal antibodies that bind and inhibit activation of human RON (Recepteur d' Origine Nantais) are disclosed. The antibodies can be used to treat certain forms of cancer that are associated with activation of RON.
Bibliography:Application Number: US201113177071